Funding Rounds
Anaveon

Anaveon Series A (2019, $34M)

Anaveon

IL-2 complexes selectively enhance effector T cell functions.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $34.96M

Raised Date: 2019-01-01

Investors